Trials / Completed
CompletedNCT00863005
Assessment of the Effects on Barrier Impairment, Clinical Features and Bacterial Colonization of Topical Formulations in Patients With Atopic Eczema; a Phase IIa, Single-center, Randomized, Observer-blind Study
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Moberg Pharma AB · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is the assessment of the barrier impairment, clinical skin condition and bacterial colonization status in patients with atopic eczema following topical treatment with K201 cream and a comparator twice daily over a 4-week treatment period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | K201 | Cream |
| DRUG | K201 |
Timeline
- First posted
- 2009-03-17
- Last updated
- 2009-11-06
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00863005. Inclusion in this directory is not an endorsement.